BSE announces demat auction settlement for delivery shortages across 127 scrips scheduled for February 2, 2026.
Impact
Low
Severity
Low
Justification
Routine demat auction settlement affecting multiple scrips with relatively small quantities. Standard market operation procedure for handling delivery shortages.
NSE notifies the listing of additional equity shares for 13 companies including CG Power, DCB Bank, Emkay Global, Federal Bank, and others, effective February 01, 2026.
Impact
Low
Severity
Low
Justification
Routine administrative listing of additional shares from ESOP allotments and preferential issues. Minimal impact on existing shareholders due to small quantities relative to total outstanding shares.
BSE announces listing and trading admission of further securities issued under ESOP/ESOS schemes by 10 companies, effective February 1, 2026.
Impact
Low
Severity
Low
Justification
Routine administrative listing of shares issued under employee stock option schemes. Minimal market impact as shares are subject to standard ESOP vesting and selling restrictions.
BSE announces demat auction for settlement number 807 covering 143 scrips with specified quantities for auction settlement dated January 29, 2026.
Impact
Medium
Severity
Medium
Justification
Routine demat auction covering 143 scrips with varying quantities. Affects multiple market participants with delivery obligations but is a standard settlement mechanism for addressing delivery shortages.
List of securities and quantities to be auctioned in demat auction settlement number 807 scheduled for January 29, 2026.
Impact
Medium
Severity
Medium
Justification
Regular demat auction notice affecting multiple securities with specific settlement obligations for trading members. Impacts brokers and investors with pending delivery obligations.
BSE announces demat auction for settlement number 798 covering 100 scrips with various quantities for physical delivery settlement.
Impact
Low
Severity
Low
Justification
Routine demat auction for physical delivery settlement affecting specific quantities of select scrips. Limited market-wide impact as it relates to settlement process rather than regulatory changes.